Tango Therapeutics, Inc. (TNGX)
22.33
-0.51
(-2.23%)
USD |
NASDAQ |
Sep 01, 10:23
Tango Therapeutics Cash from Operations (Annual) : -138.89M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -138.89M |
| December 31, 2024 | -131.50M |
| December 31, 2023 | -117.98M |
| Date | Value |
|---|---|
| December 31, 2022 | -109.08M |
| December 31, 2021 | -59.53M |
| December 31, 2020 | 70.07M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Revolution Medicines, Inc. | -897.74M |
| Erasca, Inc. | -95.46M |
| NovelStem International Corp. | -0.1676M |
| Brainstorm Cell Therapeutics, Inc. | -6.975M |
| Summit Therapeutics, Inc. | -322.93M |